SLEEK - A Highly Efficient Transgene Knock-in Technology in Clinically Relevant Cell Types

Explore a groundbreaking webinar on SLEEK, a highly efficient transgene knock-in technology for clinically relevant cell types, presented by Dr. John Zuris, Director of Editing Technologies at Editas Medicine. Delve into the challenges of inefficient transgene cargo knock-in and discover how this innovative CRISPR-based approach targets an essential gene exon while integrating desired transgenes. Learn about the potential impact on cell-based medicines and gain insights from Dr. Zuris's eight years of experience in developing gene editing platform advancements. Earn PACE credits by watching the 36-minute presentation and following the provided instructions. Connect with Labroots on various social media platforms for more cutting-edge scientific content.

SLEEK: A highly efficient transgene knock-in technology in clinically relevant cell types